Allergy and Respiratory Expertise

Operational excellence in Allergy & Respiratory trials

Your goal is to differentiate and deliver the best respiratory allergy treatments in a competitive arena. We can help.

Iqvia Human data science

OUR DIFFERENCE

Proven success and expertise, driven by strategy

When you combine our domain expertise with our allergy therapeutic expertise, the result is an allergy partner with extensive experience in addressing the challenges faced in this complex and highly competitive space. The expert combination of therapeutic strategy, medical strategy, and program management result in an established, effective approach.

  • 100% of the bestselling respiratory drugs from 2016–2023 were developed with our help
  • We have provided clinical services for 63 Phase I to IV asthma studies, involving approximately 12,090 patients in 65 countries worldwide
Iqvia Human data science

IQVIA’S experience

Experience in all the facets of Allergy & Respiratory

We have broad expertise ranging from chronic inflammatory airway disorders such as Asthma and COPD to allergic disorders including Allergic Rhinitis and Food Allergies. Here are some of the other areas we’ve studied:

  • Chronic Rhinosinusitis
  • Pulmonary Fibrosis
  • Cystic Fibrosis
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Angioedema
  • Immunodeficiency diseases
  • Long COVID
  • Pneumonia
  • Lung Cancer
Woman using tablet in home

DECENTRALIZED TRIALS

Proven, flexible DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and industry-leading technologies that engage the right patients wherever they are.

Related Solutions

Contact Us